Last reviewed · How we verify

NCT04857190

Parker Flex-it Stylet Versus Malleable Stylet in Orotracheal Intubation Using a Fiber-optic Laryngoscope

Completed NA Last updated 22 April 2022
What this trial tests

NA trial testing Parker Flex-it Directional Stylet in Orotracheal Intubation in 80 participants. Completed in 15 March 2022.

Timeline
1 May 2021
Primary endpoint
15 March 2022
15 March 2022

Quick facts

Lead sponsorDamanhour Teaching Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment80
Start date1 May 2021
Primary completion15 March 2022
Estimated completion15 March 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Damanhour Teaching Hospital

Who can join

Adults 21 to 60, any sex, with Orotracheal Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: To compare the safety and efficacy of Parker flex-it directional stylet (PFDS) versus conventional malleable stylet (CMS) in orotracheal intubation (OTI) using fiber-optic Macintosh laryngoscope. Background: OTI is used in general anesthesia for anesthetic delivery and ventilation of patients. OTI delay or failure may adversely affect patient outcomes, therefore, anesthetists with sufficient clinical experience and skill should perform OTI. However, in emergency situations, experienced anesthetists may not be available, and the patient may have a high Cormack-Lehane grade. A stylet is commonly used in the emergency department to aid insertion of the endotracheal tube during direct laryngoscopy. Patients and Methods: This was a prospective, randomized, double-blind clinical trial; carried out on 80 patients requiring OTI under general anesthesia at our hospital. Patients were randomly allocated into two equal groups; group DS, intubated using PFDS, and group MS, intubated using CMS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Damanhour Teaching Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04857190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing